OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
KRAS inhibitors: resistance drivers and combinatorial strategies
Tamara Isermann, Christine Sers, Channing J. Der, et al.
Trends in cancer (2024)
Open Access | Times Cited: 6
Tamara Isermann, Christine Sers, Channing J. Der, et al.
Trends in cancer (2024)
Open Access | Times Cited: 6
Showing 6 citing articles:
Small molecules for Kirsten rat sarcoma viral oncogene homolog mutant cancers: Past, present, and future
Peiliang Dong, Jiating Ni, Xinyue Zheng, et al.
European Journal of Pharmacology (2025), pp. 177428-177428
Closed Access
Peiliang Dong, Jiating Ni, Xinyue Zheng, et al.
European Journal of Pharmacology (2025), pp. 177428-177428
Closed Access
Immunotherapy in advanced, KRAS G12C-mutant non-small-cell lung cancer: current strategies and future directions
Nadia Ghazali, Marina Chiara Garassino, Natasha B. Leighl, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Nadia Ghazali, Marina Chiara Garassino, Natasha B. Leighl, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Targeting the Yin and Yang of KRASG12C
Christos Adamopoulos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou
Trends in Molecular Medicine (2025)
Closed Access
Christos Adamopoulos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou
Trends in Molecular Medicine (2025)
Closed Access
Farnesyl Transferase Inhibitors as a Novel Strategy for Targeting KRAS-Dependent Cancers
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 4, pp. 517-519
Closed Access
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 4, pp. 517-519
Closed Access
Pancreatic cancer: failures and hopes—a review of new promising treatment approaches
Vittore Cereda, Mario D’Andrea
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Vittore Cereda, Mario D’Andrea
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
PRMT5 inhibitors: Therapeutic potential in pancreatic cancer
Carolin Schneider, Valentina Spielmann, Christian Braun, et al.
Translational Oncology (2025) Vol. 55, pp. 102366-102366
Closed Access
Carolin Schneider, Valentina Spielmann, Christian Braun, et al.
Translational Oncology (2025) Vol. 55, pp. 102366-102366
Closed Access
Current status of KRAS G12C inhibitors in NSCLC and the potential for combination with anti-PD-(L)1 therapy: a systematic review
Fan Zhang, Banglu Wang, Menghuan Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Fan Zhang, Banglu Wang, Menghuan Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
